Review



theros h/i (hoxb13:il17br  (bioTheranostics)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    bioTheranostics theros h/i (hoxb13:il17br
    Theros H/I (Hoxb13:Il17br, supplied by bioTheranostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/theros/theros+breast+cancer+index/pmc03022545-157-38-39
    Average 90 stars, based on 1 article reviews
    theros h/i (hoxb13:il17br - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: The past and future of breast cancer treatment-from the papyrus to individualised treatment approaches.
    Article Snippet: Currently, several of these first-generation prognostic gene signatures are clinically available: (i) Endopredict (Sividon Diagnostics, Cologne, Germany) (ii) MammaPrint (Agendia, Amsterdam, the Netherlands), (iii) MapQuant DX (Ispogen, Marseille, France), (iv) Oncotype DX (Genomic Health, CA, USA), (v) PAM50 (Nanostring Technologies, WA, USA), (vi) Theros (bioTheranostics, CA, USA), (v) (Table 2).

    Article Title: The past and future of breast cancer treatment—from the papyrus to individualised treatment approaches
    Article Snippet: Currently, several of these first-generation prognostic gene signatures are clinically available: (i) Endopredict (Sividon Diagnostics, Cologne, Germany) (ii) MammaPrint (Agendia, Amsterdam, the Netherlands), (iii) MapQuant DX (Ispogen, Marseille, France), (iv) Oncotype DX (Genomic Health, CA, USA), (v) PAM50 (Nanostring Technologies, WA, USA), (vi) Theros (bioTheranostics, CA, USA), (v) ( ).

    Article Title: The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade.
    Article Snippet: These studies have led to the development of Theros, a qRT–PCR-based test performed in a central laboratory and commercialized by Biotheranostics.

    Clinical Proteomics:

    Article Title: Personalized therapy for breast cancer: a dream or a reality?
    Article Snippet: part of Personalized cancer medicine, defined as a customized approach to any given patient, based on the patient’s and tumor’s characteristics, has been in practice for breast cancer patients, even in its infancy, before the term was coined.. This can be exemplified by the use of ER expression status as a tool to guide the application of endocrine treatment.. The advent of gene-expression profiling ana lysis techniques, more than 10 years ago, provided a substantial boost to the field of personalized breast cancer medicine; they served as the workhorse for the identification of molecular subtypes of the disease, informing us about the molecular diversity underpinning this common disease [1–4], and they led to the generation of multigene prognostic classifiers, providing additional prognostic information to the common clinicopathologic parameters [5].



    Similar Products

    dl thero mic  (MedChemExpress)
    93
    MedChemExpress dl thero mic
    Dl Thero Mic, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/theros/Miconazole/pmc09728974-391-8-9
    Average 93 stars, based on 1 article reviews
    dl thero mic - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    x-ray photoelectron spectrometer thero scientific k-alpha  (Thermo Fisher)
    90
    Thermo Fisher x-ray photoelectron spectrometer thero scientific k-alpha
    X Ray Photoelectron Spectrometer Thero Scientific K Alpha, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/theros/x+ray+photoelectron+spectrometer+thero+scientific+k+alpha/pm39884618-61-6-11
    Average 90 stars, based on 1 article reviews
    x-ray photoelectron spectrometer thero scientific k-alpha - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    incubator thero fisher scientific  (Fisher Scientific)
    90
    Fisher Scientific incubator thero fisher scientific
    Incubator Thero Fisher Scientific, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/theros/incubator+thero+fisher+scientific/pmc10530868__SC___014___D3SC01537H___s001-77-6-8
    Average 90 stars, based on 1 article reviews
    incubator thero fisher scientific - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    theros h/i (hoxb13:il17br  (bioTheranostics)
    90
    bioTheranostics theros h/i (hoxb13:il17br
    Theros H/I (Hoxb13:Il17br, supplied by bioTheranostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/theros/theros+breast+cancer+index/pmc03022545-157-38-39
    Average 90 stars, based on 1 article reviews
    theros h/i (hoxb13:il17br - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    theros  (bioTheranostics)
    90
    bioTheranostics theros
    Summary of commercially available, first-generation, multigene prognosticators in breast cancer.
    Theros, supplied by bioTheranostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/theros/theros+breast+cancer+index/pmc05481194-98-42-44
    Average 90 stars, based on 1 article reviews
    theros - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    scanning electron microscope sem thero fei nova nano 450  (Thermo Fisher)
    90
    Thermo Fisher scanning electron microscope sem thero fei nova nano 450
    Fabrication and characterization of the MN-MSC patch. a) Schematic of MN-MSC patch fabrication process by a1) casting, a2) blue light crosslinking, a3) peeled off from PDMS mold and adding GelMA solution with MSCs, a4) blue light crosslinking. b) <t>SEM</t> image of b1) interstructure of normal and b2) porous GelMA hydrogel. Scale bars of images (b1, b2) indicate 300µm, and scale bars of images (b3, b4) indicate 100um. c) Calcein (live)/EthD (dead) staining revealed the morphology and viability of MSC encapsulated in GelMA hydrogel on c1) day 3 and c2) day 5. Scale bars: 200 μm. d) The quantitative viability analysis of MSC encapsulated in GelMA hydrogel on days 1, 3 and 5. Data were analyzed with one-way ANOVA followed by Tukey’s post hoc test. n=4. *p<0.05. e) Representative optical microscopy images and f-g) SEM (scanning electron <t>microscope)</t> images of MN. Scale bars for images f) indicate 500 µm, and scale bars for images g) indicate 50 µm. h) The mechanical strength of MN. i) Schematic showing the study design used to test the releasing profile of exosomes from the MN-MSC patch. j) The daily exosome release curves of MN-MSC patch fabricated with porous and normal GelMA hydrogel. Data are presented as means ± SD (n = 3 for each group). k) The daily exosome release curves of MN-MSC and MN-EXO patch. Data are presented as means ± SD (n = 3 for each group).
    Scanning Electron Microscope Sem Thero Fei Nova Nano 450, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/theros/bio_rxiv__2022__07__18__500400-152-9-14
    Average 90 stars, based on 1 article reviews
    scanning electron microscope sem thero fei nova nano 450 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    thero- finnigan instrument  (Finnigan Corporation)
    90
    Finnigan Corporation thero- finnigan instrument
    Fabrication and characterization of the MN-MSC patch. a) Schematic of MN-MSC patch fabrication process by a1) casting, a2) blue light crosslinking, a3) peeled off from PDMS mold and adding GelMA solution with MSCs, a4) blue light crosslinking. b) <t>SEM</t> image of b1) interstructure of normal and b2) porous GelMA hydrogel. Scale bars of images (b1, b2) indicate 300µm, and scale bars of images (b3, b4) indicate 100um. c) Calcein (live)/EthD (dead) staining revealed the morphology and viability of MSC encapsulated in GelMA hydrogel on c1) day 3 and c2) day 5. Scale bars: 200 μm. d) The quantitative viability analysis of MSC encapsulated in GelMA hydrogel on days 1, 3 and 5. Data were analyzed with one-way ANOVA followed by Tukey’s post hoc test. n=4. *p<0.05. e) Representative optical microscopy images and f-g) SEM (scanning electron <t>microscope)</t> images of MN. Scale bars for images f) indicate 500 µm, and scale bars for images g) indicate 50 µm. h) The mechanical strength of MN. i) Schematic showing the study design used to test the releasing profile of exosomes from the MN-MSC patch. j) The daily exosome release curves of MN-MSC patch fabricated with porous and normal GelMA hydrogel. Data are presented as means ± SD (n = 3 for each group). k) The daily exosome release curves of MN-MSC and MN-EXO patch. Data are presented as means ± SD (n = 3 for each group).
    Thero Finnigan Instrument, supplied by Finnigan Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/theros/thero++finnigan+instrument/10__1016_slash_j__cattod__2017__05__057-41-9-10
    Average 90 stars, based on 1 article reviews
    thero- finnigan instrument - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    theros breast cancer indexsm (bci)  (bioTheranostics)
    90
    bioTheranostics theros breast cancer indexsm (bci)
    Fabrication and characterization of the MN-MSC patch. a) Schematic of MN-MSC patch fabrication process by a1) casting, a2) blue light crosslinking, a3) peeled off from PDMS mold and adding GelMA solution with MSCs, a4) blue light crosslinking. b) <t>SEM</t> image of b1) interstructure of normal and b2) porous GelMA hydrogel. Scale bars of images (b1, b2) indicate 300µm, and scale bars of images (b3, b4) indicate 100um. c) Calcein (live)/EthD (dead) staining revealed the morphology and viability of MSC encapsulated in GelMA hydrogel on c1) day 3 and c2) day 5. Scale bars: 200 μm. d) The quantitative viability analysis of MSC encapsulated in GelMA hydrogel on days 1, 3 and 5. Data were analyzed with one-way ANOVA followed by Tukey’s post hoc test. n=4. *p<0.05. e) Representative optical microscopy images and f-g) SEM (scanning electron <t>microscope)</t> images of MN. Scale bars for images f) indicate 500 µm, and scale bars for images g) indicate 50 µm. h) The mechanical strength of MN. i) Schematic showing the study design used to test the releasing profile of exosomes from the MN-MSC patch. j) The daily exosome release curves of MN-MSC patch fabricated with porous and normal GelMA hydrogel. Data are presented as means ± SD (n = 3 for each group). k) The daily exosome release curves of MN-MSC and MN-EXO patch. Data are presented as means ± SD (n = 3 for each group).
    Theros Breast Cancer Indexsm (Bci), supplied by bioTheranostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/theros/theros+breast+cancer+index/us09696313-517-75-80
    Average 90 stars, based on 1 article reviews
    theros breast cancer indexsm (bci) - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    thero-chenopodietea  (Lohmeyer GmbH)
    90
    Lohmeyer GmbH thero-chenopodietea
    Fabrication and characterization of the MN-MSC patch. a) Schematic of MN-MSC patch fabrication process by a1) casting, a2) blue light crosslinking, a3) peeled off from PDMS mold and adding GelMA solution with MSCs, a4) blue light crosslinking. b) <t>SEM</t> image of b1) interstructure of normal and b2) porous GelMA hydrogel. Scale bars of images (b1, b2) indicate 300µm, and scale bars of images (b3, b4) indicate 100um. c) Calcein (live)/EthD (dead) staining revealed the morphology and viability of MSC encapsulated in GelMA hydrogel on c1) day 3 and c2) day 5. Scale bars: 200 μm. d) The quantitative viability analysis of MSC encapsulated in GelMA hydrogel on days 1, 3 and 5. Data were analyzed with one-way ANOVA followed by Tukey’s post hoc test. n=4. *p<0.05. e) Representative optical microscopy images and f-g) SEM (scanning electron <t>microscope)</t> images of MN. Scale bars for images f) indicate 500 µm, and scale bars for images g) indicate 50 µm. h) The mechanical strength of MN. i) Schematic showing the study design used to test the releasing profile of exosomes from the MN-MSC patch. j) The daily exosome release curves of MN-MSC patch fabricated with porous and normal GelMA hydrogel. Data are presented as means ± SD (n = 3 for each group). k) The daily exosome release curves of MN-MSC and MN-EXO patch. Data are presented as means ± SD (n = 3 for each group).
    Thero Chenopodietea, supplied by Lohmeyer GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/theros/thero+chenopodietea/10__1111_slash_avsc__12257-3665-34-38
    Average 90 stars, based on 1 article reviews
    thero-chenopodietea - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Summary of commercially available, first-generation, multigene prognosticators in breast cancer.

    Journal: ecancermedicalscience

    Article Title: The past and future of breast cancer treatment—from the papyrus to individualised treatment approaches

    doi: 10.3332/ecancer.2017.746

    Figure Lengend Snippet: Summary of commercially available, first-generation, multigene prognosticators in breast cancer.

    Article Snippet: Currently, several of these first-generation prognostic gene signatures are clinically available: (i) Endopredict (Sividon Diagnostics, Cologne, Germany) (ii) MammaPrint (Agendia, Amsterdam, the Netherlands), (iii) MapQuant DX (Ispogen, Marseille, France), (iv) Oncotype DX (Genomic Health, CA, USA), (v) PAM50 (Nanostring Technologies, WA, USA), (vi) Theros (bioTheranostics, CA, USA), (v) ( ).

    Techniques:

    Fabrication and characterization of the MN-MSC patch. a) Schematic of MN-MSC patch fabrication process by a1) casting, a2) blue light crosslinking, a3) peeled off from PDMS mold and adding GelMA solution with MSCs, a4) blue light crosslinking. b) SEM image of b1) interstructure of normal and b2) porous GelMA hydrogel. Scale bars of images (b1, b2) indicate 300µm, and scale bars of images (b3, b4) indicate 100um. c) Calcein (live)/EthD (dead) staining revealed the morphology and viability of MSC encapsulated in GelMA hydrogel on c1) day 3 and c2) day 5. Scale bars: 200 μm. d) The quantitative viability analysis of MSC encapsulated in GelMA hydrogel on days 1, 3 and 5. Data were analyzed with one-way ANOVA followed by Tukey’s post hoc test. n=4. *p<0.05. e) Representative optical microscopy images and f-g) SEM (scanning electron microscope) images of MN. Scale bars for images f) indicate 500 µm, and scale bars for images g) indicate 50 µm. h) The mechanical strength of MN. i) Schematic showing the study design used to test the releasing profile of exosomes from the MN-MSC patch. j) The daily exosome release curves of MN-MSC patch fabricated with porous and normal GelMA hydrogel. Data are presented as means ± SD (n = 3 for each group). k) The daily exosome release curves of MN-MSC and MN-EXO patch. Data are presented as means ± SD (n = 3 for each group).

    Journal: bioRxiv

    Article Title: Porous microneedle patch with sustained exosomes delivery repairs severe spinal cord injury

    doi: 10.1101/2022.07.18.500400

    Figure Lengend Snippet: Fabrication and characterization of the MN-MSC patch. a) Schematic of MN-MSC patch fabrication process by a1) casting, a2) blue light crosslinking, a3) peeled off from PDMS mold and adding GelMA solution with MSCs, a4) blue light crosslinking. b) SEM image of b1) interstructure of normal and b2) porous GelMA hydrogel. Scale bars of images (b1, b2) indicate 300µm, and scale bars of images (b3, b4) indicate 100um. c) Calcein (live)/EthD (dead) staining revealed the morphology and viability of MSC encapsulated in GelMA hydrogel on c1) day 3 and c2) day 5. Scale bars: 200 μm. d) The quantitative viability analysis of MSC encapsulated in GelMA hydrogel on days 1, 3 and 5. Data were analyzed with one-way ANOVA followed by Tukey’s post hoc test. n=4. *p<0.05. e) Representative optical microscopy images and f-g) SEM (scanning electron microscope) images of MN. Scale bars for images f) indicate 500 µm, and scale bars for images g) indicate 50 µm. h) The mechanical strength of MN. i) Schematic showing the study design used to test the releasing profile of exosomes from the MN-MSC patch. j) The daily exosome release curves of MN-MSC patch fabricated with porous and normal GelMA hydrogel. Data are presented as means ± SD (n = 3 for each group). k) The daily exosome release curves of MN-MSC and MN-EXO patch. Data are presented as means ± SD (n = 3 for each group).

    Article Snippet: The morphology of the MNs was assessed with a scanning electron microscope (SEM) (Thero FEI, Nova Nano 450).

    Techniques: Staining, Microscopy